Puylaert Kevin
SOPHiA GENETICS S.A. · Chief Sales Officer
Puylaert Kevin is listed in filings as Chief Sales Officer at SOPHiA GENETICS S.A.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to SOPHiA GENETICS S.A. (SOPH). The current snapshot covers public activity from Mar 20, 2026 to May 20, 2026. Reported amounts are shown as $150 to $2.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $16833 shares | SellApr 20, 2026 | $5.08 | $5.02 | |
| $2.7k548 shares | SellApr 6, 2026 | $4.86 | $5.02 | |
| $22446 shares | SellApr 6, 2026 | $4.86 | $5.02 | |
| $14530 shares | SellApr 6, 2026 | $4.83 | $5.02 | |
| $143 shares | SellMar 31, 2026 | $4.71 | $5.02 | |
| $15733 shares | SellMar 19, 2026 | $4.76 | $5.02 |